BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27848972)

  • 1. Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling.
    Guan Z; Li C; Fan J; He D; Li L
    Sci Rep; 2016 Nov; 6():37085. PubMed ID: 27848972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer.
    Chen C; Xu ZQ; Zong YP; Ou BC; Shen XH; Feng H; Zheng MH; Zhao JK; Lu AG
    Cell Death Dis; 2019 Feb; 10(3):178. PubMed ID: 30792394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K→︀AKT→︀GSK3β→︀AM signaling.
    Chen Y; Li C; Xie H; Fan Y; Yang Z; Ma J; He D; Li L
    Oncogene; 2017 May; 36(20):2879-2888. PubMed ID: 28114284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status.
    Chen Y; Sun Y; Rao Q; Xu H; Li L; Chang C
    Oncotarget; 2015 Oct; 6(31):31203-15. PubMed ID: 26304926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR) → c-Myc signals.
    Song W; Li L; He D; Xie H; Chen J; Yeh CR; Chang LS; Yeh S; Chang C
    Cancer Lett; 2015 Nov; 368(1):71-78. PubMed ID: 26231735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.
    Zhai W; Sun Y; Jiang M; Wang M; Gasiewicz TA; Zheng J; Chang C
    Oncogene; 2016 Sep; 35(37):4866-80. PubMed ID: 26973243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.
    Yue D; Wang Y; Sun Y; Niu Y; Chang C
    Neoplasia; 2017 Feb; 19(2):135-144. PubMed ID: 28107702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltrating macrophages increase RCC epithelial mesenchymal transition (EMT) and stem cell-like populations via AKT and mTOR signaling.
    Yang Z; Xie H; He D; Li L
    Oncotarget; 2016 Jul; 7(28):44478-44491. PubMed ID: 27283897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.
    Zhai W; Sun Y; Guo C; Hu G; Wang M; Zheng J; Lin W; Huang Q; Li G; Zheng J; Chang C
    Cell Death Differ; 2017 Sep; 24(9):1502-1517. PubMed ID: 28644440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
    Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
    J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth.
    Wang K; Sun Y; Guo C; Liu T; Fei X; Chang C
    Cell Death Dis; 2019 Apr; 10(5):339. PubMed ID: 31000693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-κB/MMP-9 signaling.
    Chen S; Liu W; Wang K; Fan Y; Chen J; Ma J; Wang X; He D; Zeng J; Li L
    PLoS One; 2017; 12(3):e0173725. PubMed ID: 28288190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors.
    Pak S; Kim W; Kim Y; Song C; Ahn H
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2293-2301. PubMed ID: 31401673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism.
    Wu ST; Sun GH; Hsu CY; Huang CS; Wu YH; Wang HH; Sun KH
    Exp Biol Med (Maywood); 2011 Sep; 236(9):1022-9. PubMed ID: 21856755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CARD10 promotes the progression of renal cell carcinoma by regulating the NF‑κB signaling pathway.
    Peng L; He K; Cao Z; Bi L; Yu D; Wang Q; Wang J
    Mol Med Rep; 2020 Jan; 21(1):329-337. PubMed ID: 31939627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASC-J9 suppresses renal cell carcinoma progression by targeting an androgen receptor-dependent HIF2α/VEGF signaling pathway.
    He D; Li L; Zhu G; Liang L; Guan Z; Chang L; Chen Y; Yeh S; Chang C
    Cancer Res; 2014 Aug; 74(16):4420-30. PubMed ID: 24924778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity.
    Lin YW; Lee LM; Lee WJ; Chu CY; Tan P; Yang YC; Chen WY; Yang SF; Hsiao M; Chien MH
    J Pineal Res; 2016 Apr; 60(3):277-90. PubMed ID: 26732239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of RICTOR gene transcription by the proinflammatory cytokines through NF-κB pathway contributes to the metastasis of renal cell carcinoma.
    Sun B; Chen L; Fu H; Guo L; Guo H; Zhang N
    Tumour Biol; 2016 Apr; 37(4):4457-66. PubMed ID: 26500094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis.
    Gong D; Sun Y; Guo C; Sheu TJ; Zhai W; Zheng J; Chang C
    Clin Transl Med; 2021 Mar; 11(3):e353. PubMed ID: 33783995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOTAIR and androgen receptor synergistically increase GLI2 transcription to promote tumor angiogenesis and cancer stemness in renal cell carcinoma.
    Bai JY; Jin B; Ma JB; Liu TJ; Yang C; Chong Y; Wang X; He D; Guo P
    Cancer Lett; 2021 Feb; 498():70-79. PubMed ID: 33157157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.